Baxter Cash Flow from Investing Activities 2010-2024 | BAX
- Baxter cash flow from investing activities for the quarter ending March 31, 2024 was $-0.166B, a 2.35% decline year-over-year.
- Baxter cash flow from investing activities for the twelve months ending March 31, 2024 was $6.147B, a 371.15% decline year-over-year.
- Baxter annual cash flow from investing activities for 2023 was $3.213B, a 445.11% decline from 2022.
- Baxter annual cash flow from investing activities for 2022 was $-0.931B, a 91.69% decline from 2021.
- Baxter annual cash flow from investing activities for 2021 was $-11.2B, a 849.96% increase from 2020.
Baxter Annual Cash Flow Investing (Millions of US $) |
|
---|---|
2023 | $3,213 |
2022 | $-931 |
2021 | $-11,200 |
2020 | $-1,179 |
2019 | $-1,100 |
2018 | $-916 |
2017 | $-1,292 |
2016 | $-715 |
2015 | $-1,807 |
2014 | $-1,542 |
2013 | $-5,362 |
2012 | $-1,569 |
2011 | $-1,427 |
2010 | $-1,264 |
2009 | $-1,146 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $16.913B | $14.813B |
Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $175.233B | 22.94 |
Stryker (SYK) | United States | $129.957B | 31.13 |
Boston Scientific (BSX) | United States | $110.003B | 35.04 |
Medtronic (MDT) | Ireland | $108.204B | 15.64 |
EssilorLuxottica (ESLOY) | France | $99.874B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $39.398B | 0.00 |
Haleon (HLN) | United Kingdom | $38.127B | 27.83 |
ResMed (RMD) | United States | $30.257B | 28.41 |
Koninklijke Philips (PHG) | Netherlands | $25.296B | 19.60 |
Terumo (TRUMY) | Japan | $25.163B | 35.54 |
Zimmer Biomet Holdings (ZBH) | United States | $23.688B | 15.13 |
Insulet (PODD) | United States | $12.064B | 53.49 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.877B | 0.00 |
Demant (WILYY) | Denmark | $10.259B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $8.130B | 26.59 |
BellRing Brands (BRBR) | United States | $7.607B | 35.78 |
Lantheus Holdings (LNTH) | United States | $5.529B | 13.78 |
GN Store Nord (GNNDY) | Denmark | $4.717B | 26.49 |
Haemonetics (HAE) | United States | $4.448B | 21.98 |
Perrigo (PRGO) | Ireland | $3.708B | 11.24 |
Envista Holdings (NVST) | United States | $3.128B | 12.91 |
Prestige Consumer Healthcare (PBH) | United States | $3.126B | 14.87 |
QuidelOrtho (QDEL) | United States | $2.927B | 16.25 |
Neogen (NEOG) | United States | $2.853B | 27.44 |
TG Therapeutics (TGTX) | United States | $2.528B | 71.13 |
ICU Medical (ICUI) | United States | $2.464B | 21.75 |
Green Thumb Industries (GTBIF) | United States | $2.303B | 45.62 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.250B | 0.00 |
Agios Pharmaceuticals (AGIO) | United States | $2.157B | 0.00 |
LeMaitre Vascular (LMAT) | United States | $1.765B | 51.74 |
Warby Parker (WRBY) | United States | $1.662B | 0.00 |
InMode (INMD) | Israel | $1.576B | 8.38 |
Verano Holdings (VRNOF) | United States | $1.342B | 0.00 |
AdaptHealth (AHCO) | United States | $1.331B | 9.89 |
Owens & Minor (OMI) | United States | $1.329B | 11.58 |
National Vision Holdings (EYE) | United States | $1.113B | 35.42 |
AtriCure (ATRC) | United States | $1.028B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.994B | 0.00 |
Evolus (EOLS) | United States | $0.791B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.735B | 15.65 |
Canopy Growth (CGC) | Canada | $0.714B | 0.00 |
Quanterix (QTRX) | United States | $0.619B | 0.00 |
Valneva SE (VALN) | France | $0.619B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.617B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.612B | 14.39 |
Surmodics (SRDX) | United States | $0.600B | 37.59 |
PetIQ (PETQ) | United States | $0.594B | 19.19 |
Jin Medical (ZJYL) | China | $0.476B | 0.00 |
ZimVie (ZIMV) | United States | $0.444B | 37.84 |
TerrAscend (TSNDF) | Canada | $0.434B | 0.00 |
Biote (BTMD) | United States | $0.417B | 9.60 |
OraSure Technologies (OSUR) | United States | $0.346B | 11.14 |
Aurora Cannabis (ACB) | Canada | $0.337B | 0.00 |
Cerus (CERS) | United States | $0.325B | 0.00 |
Zynex (ZYXI) | United States | $0.318B | 43.56 |
Viemed Healthcare (VMD) | United States | $0.273B | 27.00 |
Sanara MedTech (SMTI) | United States | $0.265B | 0.00 |
MacroGenics (MGNX) | United States | $0.259B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.241B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.240B | 15.11 |
TriSalus Life Sciences (TLSI) | United States | $0.204B | 0.00 |
Omeros (OMER) | United States | $0.191B | 0.00 |
High Tide (HITI) | Canada | $0.189B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.179B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.178B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.153B | 73.30 |
Veru (VERU) | United States | $0.146B | 0.00 |
InterCure (INCR) | Israel | $0.143B | 24.08 |
FitLife Brands (FTLF) | United States | $0.142B | 20.13 |
Quipt Home Medical (QIPT) | United States | $0.141B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.117B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.106B | 0.00 |
Fonar (FONR) | United States | $0.097B | 8.30 |
Brainsway (BWAY) | Israel | $0.094B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
Chimerix (CMRX) | United States | $0.082B | 0.00 |
MariMed (MRMD) | United States | $0.082B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.077B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.064B | 0.00 |
Apyx Medical (APYX) | United States | $0.055B | 0.00 |
Safety Shot (SHOT) | United States | $0.055B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.055B | 0.00 |
Cytosorbents (CTSO) | United States | $0.049B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.043B | 2.83 |
United-Guardian (UG) | United States | $0.042B | 15.25 |
Bright Green (BGXX) | United States | $0.041B | 0.00 |
ImmuCell (ICCC) | United States | $0.034B | 0.00 |
Modular Medical (MODD) | United States | $0.034B | 0.00 |
Exagen (XGN) | United States | $0.033B | 0.00 |
Nephros (NEPH) | United States | $0.023B | 0.00 |
Agape ATP (ATPC) | $0.020B | 0.00 | |
Innovative Eyewear (LUCY) | United States | $0.017B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.016B | 0.00 |
Flora Growth (FLGC) | United States | $0.016B | 0.00 |
FSD PHARMA (HUGE) | Canada | $0.013B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.012B | 0.00 |
GlucoTrack (GCTK) | United States | $0.011B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
Sharps Technology (STSS) | United States | $0.007B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |